Coagulation Reference Values and Indications for the Use of Plasma Derivatives in Neonates: A Narrative Review

Normal levels of coagulation factors in neonates are generally lower, which lead to prolonged clotting times, namely prothrombin time and activated partial thromboplastin time. These tests are frequently requested in neonatal intensive care units, and altered values are commonly found. However, thes...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Portuguese journal of pediatrics (Online) 2022-05, Vol.53 (2)
Hauptverfasser: Todo Bom Costa, Sara, Palaré, Maria João, Mendes Graça, André
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page
container_title Portuguese journal of pediatrics (Online)
container_volume 53
creator Todo Bom Costa, Sara
Palaré, Maria João
Mendes Graça, André
description Normal levels of coagulation factors in neonates are generally lower, which lead to prolonged clotting times, namely prothrombin time and activated partial thromboplastin time. These tests are frequently requested in neonatal intensive care units, and altered values are commonly found. However, these coagulation factor deficiencies are physiologic. Developmental hemostasis is a process that leads to the progressive increase of coagulation factor levels from birth to adulthood. It is crucial to define appropriate reference values for activated partial thromboplastin time, prothrombin time, and fibrinogen levels to avoid unnecessary transfusions. Physicians tend to prophylactically transfuse neonates in the presence of abnormal test results in an attempt to correct these deficiencies and decrease bleeding risk. As these changes are not associated with an increased risk of bleeding, namely intraventricular hemorrhage, most neonates do not require the transfusion of plasma products. In fact, transfusion of blood products has risks, and transfusion recipients should be carefully selected. This review aimed to determine the reference range values for fibrinogen and clotting times (prothrombin time and activated partial thromboplastin time) in neonates. Moreover, it was attempted to identify the specific indications for the transfusion of plasma derivatives. This review emphasizes the need for evidence-based reference ranges for coagulation tests (activated partial thromboplastin time, prothrombin time, fibrinogen), in preterm and full-term infants, as well as the importance of establishing universal guidelines for the transfusions of plasma products to ensure a standard clinical approach to this subject.
format Article
fullrecord <record><control><sourceid>rcaap</sourceid><recordid>TN_cdi_rcaap_revistas_article_26058</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>article_26058</sourcerecordid><originalsourceid>FETCH-rcaap_revistas_article_260583</originalsourceid><addsrcrecordid>eNqNjM0KwjAQhIMoWNR3WPAs9FeKN_EHvRQR9VqWdquRmEg21tc3lD6Ac5mB-WYGIoijPF2kaZYM-5x4jcWM-RmGYZxFUR7ngdAbg_ePQieNhjM1ZElXBDdUH2JAXcNR17LqeobGWHAPgisTmAZOCvmFsCUrW0-0fiE1FGQ0OuIVrKFAa7vGf7eSvlMxalAxzXqfiPl-d9kcFrZCfJfWQ-yQS7ROVorKeBlmefIf9QO4TEzB</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Coagulation Reference Values and Indications for the Use of Plasma Derivatives in Neonates: A Narrative Review</title><source>Alma/SFX Local Collection</source><creator>Todo Bom Costa, Sara ; Palaré, Maria João ; Mendes Graça, André</creator><creatorcontrib>Todo Bom Costa, Sara ; Palaré, Maria João ; Mendes Graça, André</creatorcontrib><description>Normal levels of coagulation factors in neonates are generally lower, which lead to prolonged clotting times, namely prothrombin time and activated partial thromboplastin time. These tests are frequently requested in neonatal intensive care units, and altered values are commonly found. However, these coagulation factor deficiencies are physiologic. Developmental hemostasis is a process that leads to the progressive increase of coagulation factor levels from birth to adulthood. It is crucial to define appropriate reference values for activated partial thromboplastin time, prothrombin time, and fibrinogen levels to avoid unnecessary transfusions. Physicians tend to prophylactically transfuse neonates in the presence of abnormal test results in an attempt to correct these deficiencies and decrease bleeding risk. As these changes are not associated with an increased risk of bleeding, namely intraventricular hemorrhage, most neonates do not require the transfusion of plasma products. In fact, transfusion of blood products has risks, and transfusion recipients should be carefully selected. This review aimed to determine the reference range values for fibrinogen and clotting times (prothrombin time and activated partial thromboplastin time) in neonates. Moreover, it was attempted to identify the specific indications for the transfusion of plasma derivatives. This review emphasizes the need for evidence-based reference ranges for coagulation tests (activated partial thromboplastin time, prothrombin time, fibrinogen), in preterm and full-term infants, as well as the importance of establishing universal guidelines for the transfusions of plasma products to ensure a standard clinical approach to this subject.</description><identifier>ISSN: 2184-3333</identifier><identifier>EISSN: 2184-4453</identifier><language>eng</language><publisher>Sociedade Portuguesa de Pediatria</publisher><subject>Review articles</subject><ispartof>Portuguese journal of pediatrics (Online), 2022-05, Vol.53 (2)</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0001-7466-8052 ; 0000-0002-4194-7095 ; 0000-0003-2961-0083</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Todo Bom Costa, Sara</creatorcontrib><creatorcontrib>Palaré, Maria João</creatorcontrib><creatorcontrib>Mendes Graça, André</creatorcontrib><title>Coagulation Reference Values and Indications for the Use of Plasma Derivatives in Neonates: A Narrative Review</title><title>Portuguese journal of pediatrics (Online)</title><description>Normal levels of coagulation factors in neonates are generally lower, which lead to prolonged clotting times, namely prothrombin time and activated partial thromboplastin time. These tests are frequently requested in neonatal intensive care units, and altered values are commonly found. However, these coagulation factor deficiencies are physiologic. Developmental hemostasis is a process that leads to the progressive increase of coagulation factor levels from birth to adulthood. It is crucial to define appropriate reference values for activated partial thromboplastin time, prothrombin time, and fibrinogen levels to avoid unnecessary transfusions. Physicians tend to prophylactically transfuse neonates in the presence of abnormal test results in an attempt to correct these deficiencies and decrease bleeding risk. As these changes are not associated with an increased risk of bleeding, namely intraventricular hemorrhage, most neonates do not require the transfusion of plasma products. In fact, transfusion of blood products has risks, and transfusion recipients should be carefully selected. This review aimed to determine the reference range values for fibrinogen and clotting times (prothrombin time and activated partial thromboplastin time) in neonates. Moreover, it was attempted to identify the specific indications for the transfusion of plasma derivatives. This review emphasizes the need for evidence-based reference ranges for coagulation tests (activated partial thromboplastin time, prothrombin time, fibrinogen), in preterm and full-term infants, as well as the importance of establishing universal guidelines for the transfusions of plasma products to ensure a standard clinical approach to this subject.</description><subject>Review articles</subject><issn>2184-3333</issn><issn>2184-4453</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqNjM0KwjAQhIMoWNR3WPAs9FeKN_EHvRQR9VqWdquRmEg21tc3lD6Ac5mB-WYGIoijPF2kaZYM-5x4jcWM-RmGYZxFUR7ngdAbg_ePQieNhjM1ZElXBDdUH2JAXcNR17LqeobGWHAPgisTmAZOCvmFsCUrW0-0fiE1FGQ0OuIVrKFAa7vGf7eSvlMxalAxzXqfiPl-d9kcFrZCfJfWQ-yQS7ROVorKeBlmefIf9QO4TEzB</recordid><startdate>20220523</startdate><enddate>20220523</enddate><creator>Todo Bom Costa, Sara</creator><creator>Palaré, Maria João</creator><creator>Mendes Graça, André</creator><general>Sociedade Portuguesa de Pediatria</general><scope>RCLKO</scope><orcidid>https://orcid.org/0000-0001-7466-8052</orcidid><orcidid>https://orcid.org/0000-0002-4194-7095</orcidid><orcidid>https://orcid.org/0000-0003-2961-0083</orcidid></search><sort><creationdate>20220523</creationdate><title>Coagulation Reference Values and Indications for the Use of Plasma Derivatives in Neonates: A Narrative Review</title><author>Todo Bom Costa, Sara ; Palaré, Maria João ; Mendes Graça, André</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-rcaap_revistas_article_260583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Review articles</topic><toplevel>online_resources</toplevel><creatorcontrib>Todo Bom Costa, Sara</creatorcontrib><creatorcontrib>Palaré, Maria João</creatorcontrib><creatorcontrib>Mendes Graça, André</creatorcontrib><collection>RCAAP open access repository</collection><jtitle>Portuguese journal of pediatrics (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Todo Bom Costa, Sara</au><au>Palaré, Maria João</au><au>Mendes Graça, André</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Coagulation Reference Values and Indications for the Use of Plasma Derivatives in Neonates: A Narrative Review</atitle><jtitle>Portuguese journal of pediatrics (Online)</jtitle><date>2022-05-23</date><risdate>2022</risdate><volume>53</volume><issue>2</issue><issn>2184-3333</issn><eissn>2184-4453</eissn><abstract>Normal levels of coagulation factors in neonates are generally lower, which lead to prolonged clotting times, namely prothrombin time and activated partial thromboplastin time. These tests are frequently requested in neonatal intensive care units, and altered values are commonly found. However, these coagulation factor deficiencies are physiologic. Developmental hemostasis is a process that leads to the progressive increase of coagulation factor levels from birth to adulthood. It is crucial to define appropriate reference values for activated partial thromboplastin time, prothrombin time, and fibrinogen levels to avoid unnecessary transfusions. Physicians tend to prophylactically transfuse neonates in the presence of abnormal test results in an attempt to correct these deficiencies and decrease bleeding risk. As these changes are not associated with an increased risk of bleeding, namely intraventricular hemorrhage, most neonates do not require the transfusion of plasma products. In fact, transfusion of blood products has risks, and transfusion recipients should be carefully selected. This review aimed to determine the reference range values for fibrinogen and clotting times (prothrombin time and activated partial thromboplastin time) in neonates. Moreover, it was attempted to identify the specific indications for the transfusion of plasma derivatives. This review emphasizes the need for evidence-based reference ranges for coagulation tests (activated partial thromboplastin time, prothrombin time, fibrinogen), in preterm and full-term infants, as well as the importance of establishing universal guidelines for the transfusions of plasma products to ensure a standard clinical approach to this subject.</abstract><pub>Sociedade Portuguesa de Pediatria</pub><orcidid>https://orcid.org/0000-0001-7466-8052</orcidid><orcidid>https://orcid.org/0000-0002-4194-7095</orcidid><orcidid>https://orcid.org/0000-0003-2961-0083</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2184-3333
ispartof Portuguese journal of pediatrics (Online), 2022-05, Vol.53 (2)
issn 2184-3333
2184-4453
language eng
recordid cdi_rcaap_revistas_article_26058
source Alma/SFX Local Collection
subjects Review articles
title Coagulation Reference Values and Indications for the Use of Plasma Derivatives in Neonates: A Narrative Review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A22%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-rcaap&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Coagulation%20Reference%20Values%20and%20Indications%20for%20the%20Use%20of%20Plasma%20Derivatives%20in%20Neonates:%20A%20Narrative%20Review&rft.jtitle=Portuguese%20journal%20of%20pediatrics%20(Online)&rft.au=Todo%20Bom%20Costa,%20Sara&rft.date=2022-05-23&rft.volume=53&rft.issue=2&rft.issn=2184-3333&rft.eissn=2184-4453&rft_id=info:doi/&rft_dat=%3Crcaap%3Earticle_26058%3C/rcaap%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true